Barrett & Company’s iShares Biotechnology ETF IBB Stock Holding History

Barrett & Company’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$95.6K	Hold	566	–	–	0.03%	215
2025 Q4	$95.5K	Hold	566	–	–	0.03%	214
2025 Q3	$81.7K	Sell	566 -38	-6%	-$5.19K	0.03%	233
2025 Q2	$76.4K	Hold	604	–	–	0.03%	244
2025 Q1	$77.3K	Hold	604	–	–	0.03%	221
2024 Q4	$79.9K	Buy	604 +16	+3%	+$2.25K	0.03%	222
2024 Q3	$85.7K	Hold	588	–	–	0.04%	214
2024 Q2	$80.7K	Hold	588	–	–	0.04%	215
2024 Q1	$80.7K	Hold	588	–	–	0.04%	222
2023 Q4	$79.9K	Hold	588	–	–	0.04%	213
2023 Q3	$71.9K	Hold	588	–	–	0.04%	214
2023 Q2	$74.7K	Hold	588	–	–	0.04%	218
2023 Q1	$76K	Hold	588	–	–	0.05%	210
2022 Q4	$77.2K	Hold	588	–	–	0.05%	194
2022 Q3	$77.2K	Buy	+588	New	+$73K	0.05%	194

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Barrett & Company's IBB Position: Q1 2026 in Review

Barrett & Company held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 566 shares worth $95.6K. The position accounts for 0.03% of the portfolio, ranked #215.

Barrett & Company first reported a position in IBB in Q3 2022 and has held it in 15 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Barrett & Company held 566 shares of iShares Biotechnology ETF worth $95.6K as of Q1 2026.
Barrett & Company left its iShares Biotechnology ETF share count unchanged in Q1 2026.
iShares Biotechnology ETF made up 0.03% of Barrett & Company's portfolio in Q1 2026, its #215 holding.
Barrett & Company first reported a position in iShares Biotechnology ETF in Q3 2022 and has held it in 15 quarters since.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.